NCT02371252View on ClinicalTrials.gov

Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Osteoporosis
Interventions
DRUG

Generic alendronate

The patients will be given the generic alendronate 1 tablet per week for approximately 1 year after enrollment.

Trial Locations (1)

10700

Siriraj Hospital, Bangkok Noi

All Listed Sponsors
lead

Mahidol University

OTHER

NCT02371252 - Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment | Biotech Hunter | Biotech Hunter